| 51 |
25310526 | +TIP EB1 downregulates paclitaxel‑induced proliferation inhibition and apoptosis in breast cancer cells through inhibition of paclitaxel binding on microtubules. | 2015 Jan |
2 |
| 52 |
25351378 | Biological characteristics of Taxol‑resistant ovarian cancer cells and reversal of Taxol resistance by adenovirus expressing p53. | 2015 Feb |
1 |
| 53 |
25499080 | Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. | 2015 Feb 28 |
1 |
| 54 |
25596561 | Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition. | 2015 Apr 5 |
1 |
| 55 |
25633416 | 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade. | 2015 Apr |
1 |
| 56 |
25647149 | Increased chemoresistance to paclitaxel in the MCF10AT series of human breast epithelial cancer cells. | 2015 Apr |
2 |
| 57 |
25780454 | Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-κB-p53-caspase-3 pathway. | 2015 Apr |
5 |
| 58 |
26146988 | CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. | 2015 |
3 |
| 59 |
26177745 | Concentration-dependent differential effects of an epothilone analog on cell cycle and p53 signaling. | 2015 Sep |
1 |
| 60 |
26309162 | Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells. | 2015 Sep 22 |
1 |
| 61 |
24189097 | Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug. | 2014 Jan |
3 |
| 62 |
24565839 | p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death. | 2014 Mar 28 |
3 |
| 63 |
24712391 | Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. | 2014 Aug 4 |
1 |
| 64 |
24787013 | Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases. | 2014 May 1 |
1 |
| 65 |
25411964 | Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance. | 2014 |
1 |
| 66 |
25688502 | Evaluation of chemoradiotherapy with carbon ions and the influence of p53 mutational status in the colorectal carcinoma cell line HCT 116. | 2014 Nov-Dec |
1 |
| 67 |
23161364 | p53 acetylation enhances Taxol-induced apoptosis in human cancer cells. | 2013 Jan |
18 |
| 68 |
23534290 | Biochemical effects of combined action of gamma-irradiation and paclitaxel on anaplastic thyroid cancer cells. | 2013 Jan-Feb |
1 |
| 69 |
23735541 | Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition. | 2013 Nov |
1 |
| 70 |
24141649 | Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines. | 2013 Dec |
1 |
| 71 |
24381593 | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53. | 2013 |
4 |
| 72 |
24601052 | In vitro chemosensitivity assay of ascites in epithelial ovarian cancer. | 2013 |
1 |
| 73 |
22489661 | Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism. | 2012 May |
1 |
| 74 |
22493354 | Radiosensitization of p53-deficient lung cancer cells by pre-treatment with cytostatic compounds. | 2012 Apr |
1 |
| 75 |
22534478 | Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy. | 2012 Jul-Aug |
3 |
| 76 |
22549660 | Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells. | 2012 Oct |
1 |
| 77 |
22765290 | Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. | 2012 Oct |
1 |
| 78 |
22885806 | Apoptotic-like death occurs through a caspase-independent route in colon carcinoma cells undergoing mitotic catastrophe. | 2012 Dec 29 |
3 |
| 79 |
23023313 | Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. | 2012 Dec |
2 |
| 80 |
21109480 | p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. | 2011 Jan |
1 |
| 81 |
21354697 | miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. | 2011 May 1 |
1 |
| 82 |
21482024 | A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells. | 2011 Aug 1 |
1 |
| 83 |
21514041 | Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer. | 2011 Aug 28 |
2 |
| 84 |
21556366 | Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. | 2011 Apr 27 |
3 |
| 85 |
21594648 | Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. | 2011 Nov |
3 |
| 86 |
21693655 | p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905). | 2011 Aug 1 |
2 |
| 87 |
21926165 | iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe. | 2011 Nov 1 |
1 |
| 88 |
22077725 | Effects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cells. | 2011 Dec |
2 |
| 89 |
22194993 | Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo. | 2011 |
3 |
| 90 |
19918798 | Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. | 2010 Feb |
4 |
| 91 |
20178585 | Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment. | 2010 Feb 23 |
1 |
| 92 |
20624405 | Additive effects of C(2)-ceramide on paclitaxel-induced premature senescence of human lung cancer cells. | 2010 Sep 11 |
2 |
| 93 |
20661829 | Protection of p53 wild type cells from taxol by genistein in the combined treatment of lung cancer. | 2010 |
4 |
| 94 |
20878066 | Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent. | 2010 Nov |
6 |
| 95 |
20944137 | Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro. | 2010 Sep |
3 |
| 96 |
18758183 | P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents. | 2009 |
1 |
| 97 |
19052714 | TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. | 2009 Jul |
2 |
| 98 |
19148534 | Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells. | 2009 Feb |
1 |
| 99 |
19217709 | Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines. | 2009 Jun 28 |
4 |
| 100 |
19332559 | TTK/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18. | 2009 Jun |
1 |